Advertisement
Australia markets closed
  • ALL ORDS

    8,153.70
    +80.10 (+0.99%)
     
  • ASX 200

    7,896.90
    +77.30 (+0.99%)
     
  • AUD/USD

    0.6515
    -0.0003 (-0.05%)
     
  • OIL

    83.11
    -0.06 (-0.07%)
     
  • GOLD

    2,254.80
    +16.40 (+0.73%)
     
  • Bitcoin AUD

    108,566.59
    +1,288.10 (+1.20%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • AUD/EUR

    0.6037
    +0.0003 (+0.05%)
     
  • AUD/NZD

    1.0904
    +0.0001 (+0.01%)
     
  • NZX 50

    12,105.29
    +94.63 (+0.79%)
     
  • NASDAQ

    18,254.69
    -26.15 (-0.14%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • Dow Jones

    39,807.37
    +47.29 (+0.12%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • NIKKEI 225

    40,309.87
    +141.80 (+0.35%)
     

Global Upstream Bioprocessing Market to Reach $13.3 Billion by 2027

Abstract: - Global Upstream Bioprocessing Market to Reach $13. 3 Billion by 2027. - Amid the COVID-19 crisis, the global market for Upstream Bioprocessing estimated at US$5.

New York, April 20, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Upstream Bioprocessing Industry" - https://www.reportlinker.com/p06033199/?utm_source=GNW
9 Billion in the year 2020, is projected to reach a revised size of US$13.3 Billion by 2027, growing at a CAGR of 12.2% over the analysis period 2020-2027. Cell Culture, one of the segments analyzed in the report, is projected to record a 12.4% CAGR and reach US$6.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Media Preparation segment is readjusted to a revised 11.4% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $1.8 Billion, While China is Forecast to Grow at 11.7% CAGR
- The Upstream Bioprocessing market in the U.S. is estimated at US$1.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.3 Billion by the year 2027 trailing a CAGR of 11.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.6% and 10.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.9% CAGR.
- Cell Separation Segment to Record 12.8% CAGR
- In the global Cell Separation segment, USA, Canada, Japan, China and Europe will drive the 12.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1 Billion in the year 2020 will reach a projected size of US$2.4 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.6 Billion by the year 2027.

- Select Competitors (Total 34 Featured) -

  • AGC Biologics

  • Applikon Biotechnology

  • Biotech Labs Pvt. Ltd.

  • Boehringer Ingelheim International GmbH

  • CellGenix GmbH

  • Corning, Inc.

  • Danaher

  • Eppendorf AG

  • GE Healthcare

  • Lonza Group AG

  • Merck KGaA

  • Patheon N.V

  • PBS Biotech, Inc.

  • Samsung Biologics

  • Sartorius AG

  • Thermo Fisher Scientific, Inc.




Read the full report: https://www.reportlinker.com/p06033199/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Upstream
Bioprocessing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 2: World Historic Review for Upstream Bioprocessing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 3: World 15-Year Perspective for Upstream Bioprocessing
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Cell Culture by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 5: World Historic Review for Cell Culture by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Cell Culture by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Media Preparation
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 8: World Historic Review for Media Preparation by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Media Preparation by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Cell Separation
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 11: World Historic Review for Cell Separation by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Cell Separation by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Multi by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 14: World Historic Review for Multi by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Multi by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 16: World Current & Future Analysis for Single by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 17: World Historic Review for Single by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Single by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 19: USA Current & Future Analysis for Upstream
Bioprocessing by Workflow - Cell Culture, Media Preparation and
Cell Separation - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 20: USA Historic Review for Upstream Bioprocessing by
Workflow - Cell Culture, Media Preparation and Cell Separation
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 21: USA 15-Year Perspective for Upstream Bioprocessing by
Workflow - Percentage Breakdown of Value Sales for Cell
Culture, Media Preparation and Cell Separation for the Years
2012, 2020 & 2027

Table 22: USA Current & Future Analysis for Upstream
Bioprocessing by Type - Multi and Single - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 23: USA Historic Review for Upstream Bioprocessing by
Type - Multi and Single Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 24: USA 15-Year Perspective for Upstream Bioprocessing by
Type - Percentage Breakdown of Value Sales for Multi and Single
for the Years 2012, 2020 & 2027

CANADA
Table 25: Canada Current & Future Analysis for Upstream
Bioprocessing by Workflow - Cell Culture, Media Preparation and
Cell Separation - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 26: Canada Historic Review for Upstream Bioprocessing by
Workflow - Cell Culture, Media Preparation and Cell Separation
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 27: Canada 15-Year Perspective for Upstream Bioprocessing
by Workflow - Percentage Breakdown of Value Sales for Cell
Culture, Media Preparation and Cell Separation for the Years
2012, 2020 & 2027

Table 28: Canada Current & Future Analysis for Upstream
Bioprocessing by Type - Multi and Single - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 29: Canada Historic Review for Upstream Bioprocessing by
Type - Multi and Single Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 30: Canada 15-Year Perspective for Upstream Bioprocessing
by Type - Percentage Breakdown of Value Sales for Multi and
Single for the Years 2012, 2020 & 2027

JAPAN
Table 31: Japan Current & Future Analysis for Upstream
Bioprocessing by Workflow - Cell Culture, Media Preparation and
Cell Separation - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 32: Japan Historic Review for Upstream Bioprocessing by
Workflow - Cell Culture, Media Preparation and Cell Separation
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 33: Japan 15-Year Perspective for Upstream Bioprocessing
by Workflow - Percentage Breakdown of Value Sales for Cell
Culture, Media Preparation and Cell Separation for the Years
2012, 2020 & 2027

Table 34: Japan Current & Future Analysis for Upstream
Bioprocessing by Type - Multi and Single - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 35: Japan Historic Review for Upstream Bioprocessing by
Type - Multi and Single Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 36: Japan 15-Year Perspective for Upstream Bioprocessing
by Type - Percentage Breakdown of Value Sales for Multi and
Single for the Years 2012, 2020 & 2027

CHINA
Table 37: China Current & Future Analysis for Upstream
Bioprocessing by Workflow - Cell Culture, Media Preparation and
Cell Separation - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 38: China Historic Review for Upstream Bioprocessing by
Workflow - Cell Culture, Media Preparation and Cell Separation
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 39: China 15-Year Perspective for Upstream Bioprocessing
by Workflow - Percentage Breakdown of Value Sales for Cell
Culture, Media Preparation and Cell Separation for the Years
2012, 2020 & 2027

Table 40: China Current & Future Analysis for Upstream
Bioprocessing by Type - Multi and Single - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 41: China Historic Review for Upstream Bioprocessing by
Type - Multi and Single Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 42: China 15-Year Perspective for Upstream Bioprocessing
by Type - Percentage Breakdown of Value Sales for Multi and
Single for the Years 2012, 2020 & 2027

EUROPE
Table 43: Europe Current & Future Analysis for Upstream
Bioprocessing by Geographic Region - France, Germany, Italy, UK
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2020 through 2027 and % CAGR

Table 44: Europe Historic Review for Upstream Bioprocessing by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 45: Europe 15-Year Perspective for Upstream Bioprocessing
by Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2012, 2020 & 2027

Table 46: Europe Current & Future Analysis for Upstream
Bioprocessing by Workflow - Cell Culture, Media Preparation and
Cell Separation - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 47: Europe Historic Review for Upstream Bioprocessing by
Workflow - Cell Culture, Media Preparation and Cell Separation
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 48: Europe 15-Year Perspective for Upstream Bioprocessing
by Workflow - Percentage Breakdown of Value Sales for Cell
Culture, Media Preparation and Cell Separation for the Years
2012, 2020 & 2027

Table 49: Europe Current & Future Analysis for Upstream
Bioprocessing by Type - Multi and Single - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 50: Europe Historic Review for Upstream Bioprocessing by
Type - Multi and Single Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 51: Europe 15-Year Perspective for Upstream Bioprocessing
by Type - Percentage Breakdown of Value Sales for Multi and
Single for the Years 2012, 2020 & 2027

FRANCE
Table 52: France Current & Future Analysis for Upstream
Bioprocessing by Workflow - Cell Culture, Media Preparation and
Cell Separation - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 53: France Historic Review for Upstream Bioprocessing by
Workflow - Cell Culture, Media Preparation and Cell Separation
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 54: France 15-Year Perspective for Upstream Bioprocessing
by Workflow - Percentage Breakdown of Value Sales for Cell
Culture, Media Preparation and Cell Separation for the Years
2012, 2020 & 2027

Table 55: France Current & Future Analysis for Upstream
Bioprocessing by Type - Multi and Single - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 56: France Historic Review for Upstream Bioprocessing by
Type - Multi and Single Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 57: France 15-Year Perspective for Upstream Bioprocessing
by Type - Percentage Breakdown of Value Sales for Multi and
Single for the Years 2012, 2020 & 2027

GERMANY
Table 58: Germany Current & Future Analysis for Upstream
Bioprocessing by Workflow - Cell Culture, Media Preparation and
Cell Separation - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 59: Germany Historic Review for Upstream Bioprocessing by
Workflow - Cell Culture, Media Preparation and Cell Separation
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 60: Germany 15-Year Perspective for Upstream
Bioprocessing by Workflow - Percentage Breakdown of Value Sales
for Cell Culture, Media Preparation and Cell Separation for the
Years 2012, 2020 & 2027

Table 61: Germany Current & Future Analysis for Upstream
Bioprocessing by Type - Multi and Single - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 62: Germany Historic Review for Upstream Bioprocessing by
Type - Multi and Single Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 63: Germany 15-Year Perspective for Upstream
Bioprocessing by Type - Percentage Breakdown of Value Sales for
Multi and Single for the Years 2012, 2020 & 2027

ITALY
Table 64: Italy Current & Future Analysis for Upstream
Bioprocessing by Workflow - Cell Culture, Media Preparation and
Cell Separation - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 65: Italy Historic Review for Upstream Bioprocessing by
Workflow - Cell Culture, Media Preparation and Cell Separation
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 66: Italy 15-Year Perspective for Upstream Bioprocessing
by Workflow - Percentage Breakdown of Value Sales for Cell
Culture, Media Preparation and Cell Separation for the Years
2012, 2020 & 2027

Table 67: Italy Current & Future Analysis for Upstream
Bioprocessing by Type - Multi and Single - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 68: Italy Historic Review for Upstream Bioprocessing by
Type - Multi and Single Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 69: Italy 15-Year Perspective for Upstream Bioprocessing
by Type - Percentage Breakdown of Value Sales for Multi and
Single for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 70: UK Current & Future Analysis for Upstream
Bioprocessing by Workflow - Cell Culture, Media Preparation and
Cell Separation - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 71: UK Historic Review for Upstream Bioprocessing by
Workflow - Cell Culture, Media Preparation and Cell Separation
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 72: UK 15-Year Perspective for Upstream Bioprocessing by
Workflow - Percentage Breakdown of Value Sales for Cell
Culture, Media Preparation and Cell Separation for the Years
2012, 2020 & 2027

Table 73: UK Current & Future Analysis for Upstream
Bioprocessing by Type - Multi and Single - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 74: UK Historic Review for Upstream Bioprocessing by Type -
Multi and Single Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 75: UK 15-Year Perspective for Upstream Bioprocessing by
Type - Percentage Breakdown of Value Sales for Multi and Single
for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 76: Rest of Europe Current & Future Analysis for Upstream
Bioprocessing by Workflow - Cell Culture, Media Preparation and
Cell Separation - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 77: Rest of Europe Historic Review for Upstream
Bioprocessing by Workflow - Cell Culture, Media Preparation and
Cell Separation Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 78: Rest of Europe 15-Year Perspective for Upstream
Bioprocessing by Workflow - Percentage Breakdown of Value Sales
for Cell Culture, Media Preparation and Cell Separation for the
Years 2012, 2020 & 2027

Table 79: Rest of Europe Current & Future Analysis for Upstream
Bioprocessing by Type - Multi and Single - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 80: Rest of Europe Historic Review for Upstream
Bioprocessing by Type - Multi and Single Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 81: Rest of Europe 15-Year Perspective for Upstream
Bioprocessing by Type - Percentage Breakdown of Value Sales for
Multi and Single for the Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 82: Asia-Pacific Current & Future Analysis for Upstream
Bioprocessing by Workflow - Cell Culture, Media Preparation and
Cell Separation - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 83: Asia-Pacific Historic Review for Upstream
Bioprocessing by Workflow - Cell Culture, Media Preparation and
Cell Separation Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 84: Asia-Pacific 15-Year Perspective for Upstream
Bioprocessing by Workflow - Percentage Breakdown of Value Sales
for Cell Culture, Media Preparation and Cell Separation for the
Years 2012, 2020 & 2027

Table 85: Asia-Pacific Current & Future Analysis for Upstream
Bioprocessing by Type - Multi and Single - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 86: Asia-Pacific Historic Review for Upstream
Bioprocessing by Type - Multi and Single Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 87: Asia-Pacific 15-Year Perspective for Upstream
Bioprocessing by Type - Percentage Breakdown of Value Sales for
Multi and Single for the Years 2012, 2020 & 2027

REST OF WORLD
Table 88: Rest of World Current & Future Analysis for Upstream
Bioprocessing by Workflow - Cell Culture, Media Preparation and
Cell Separation - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 89: Rest of World Historic Review for Upstream
Bioprocessing by Workflow - Cell Culture, Media Preparation and
Cell Separation Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 90: Rest of World 15-Year Perspective for Upstream
Bioprocessing by Workflow - Percentage Breakdown of Value Sales
for Cell Culture, Media Preparation and Cell Separation for the
Years 2012, 2020 & 2027

Table 91: Rest of World Current & Future Analysis for Upstream
Bioprocessing by Type - Multi and Single - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 92: Rest of World Historic Review for Upstream
Bioprocessing by Type - Multi and Single Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 93: Rest of World 15-Year Perspective for Upstream
Bioprocessing by Type - Percentage Breakdown of Value Sales for
Multi and Single for the Years 2012, 2020 & 2027

IV. COMPETITION
Total Companies Profiled: 34
Read the full report: https://www.reportlinker.com/p06033199/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001